Tag: genomics
-
Forensic Genomics Company Spun-Off From Illumina
A new company is being established to provide genomics analysis systems for law enforcement, spun-off from a leading maker of genomics systems.
-
AstraZeneca, Biotech Partner on Messenger RNA Therapies
Global drug maker AstraZeneca is acquiring an option to license the rights to a technology based on genetic material transcribed from DNA, for new respiratory disease treatments.
-
Cryptography Technique Boosts Genomic Privacy
A team of geneticists and computer scientists developed a technique of analyzing disease-causing mutations in a human genome without revealing other genetic data.
-
Trial Testing Engineered Virus as Cancer Treatment
A clinical trial is underway testing a genetically engineered virus to kill cancer cells, then stimulate the immune system to treat solid tumor cancers.
-
Alliance to Develop Rare Cancer Preclinical Models
A coalition of a patient advocacy organization, research institute, and cancer research company are implanting mice with human tumors to help study a rare form of cancer.
-
Viruses Removed from Pig Organs for Human Transplants
Researchers in the U.S., Denmark, and China devised a process with genome editing to remove viruses that prevent organs from pigs from being used for human transplants.
-
Gene-Edited Skin Grafts Shown to Control Glucose Levels
Skin grafts derived from genetically edited stem cells were shown in tests with lab mice to reduce glucose levels and weight gain that result from a high-fat diet.
-
Gene Editing Could Lead to an HIV Cure
Researchers at Temple University and the University of Pittsburgh published a study, which involved gene editing to remove HIV DNA from rat and mouse models.
-
Genomics Company Acquires Open-Source Biomedical Platform
A company providing whole genome analysis is acquiring an enterprise developing open-source computational software for biomedical uses, such as precision medicine.
-
Study Underway of Depression, Bipolar Disorder Genetics
A large-scale study by two companies and a think tank started enrolling participants to learn more about the role of genetics in major depressive and bipolar disorders.